P-glycoprotein (Pgp) overactivity in pharmacoresistant epilepsy patients with focal cortical dysplasia compared to healthy controls measured using (R)-[C-11] verapamil PET and the Pgp inhibitor Tariquidar

M. Feldmann, M. -C. Asselin, S. Wang, A. McMahon, R. Hinz, J. Duncan, S. Sisodiya, M. Koepp

    Research output: Contribution to journalArticlepeer-review

    Original languageUndefined
    Article numberEP2234
    Pages (from-to)S158-S159
    Number of pages2
    JournalJournal of Neurology
    Issue numberSupplement 1
    Publication statusPublished - 1 May 2014

    Cite this